Low Field MRI for Brain Imaging
Trial Summary
What is the purpose of this trial?
Hyperfine Research, Inc. has taken advantage of technological advances and developed an MRI device that is not only portable, but also uses a very-low magnetic field strength, \[less than 0.2 Tesla or approximately 10 times less\] than the field strength of conventional devices. This critical difference allows HRI to address MRI's core challenges by, first, operating at very low magnetic field strengths, eliminating the need for special rooms or shielding. Second, there are minimal safety concerns regarding ferrous metals near the system, as the field strength is too low to attract metal objects. The removal of metal, including items such as jewelry, belts, etc. from clothing and person, prior to being scanned, is unnecessary. Third, the design constraints faced by conventional MRI systems are lifted at low magnetic field and an open device has been designed to minimize anxiety that may come with claustrophobic patients. All of this is possible while still providing image quality that is clinically relevant to a wide variety of fields, including radiology, neurology, pediatrics, emergency medicine, and others.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, it mentions that sedation, if already administered, will not be altered for the study.
What data supports the effectiveness of the treatment Hyperfine MRI, Swoop, Swoop Portable MR Imaging System, Hyperfine Swoop for brain imaging?
Research shows that portable low-field MRI systems, like the Hyperfine Swoop, can provide effective brain imaging by using low power and being easily transportable, which allows for scanning outside traditional MRI environments. These systems have been shown to produce clinically useful images with good contrast and reduced sensitivity to motion, making them accessible and practical for bedside imaging.12345
Is Low Field MRI for Brain Imaging safe for humans?
How is the Hyperfine MRI treatment different from other brain imaging treatments?
The Hyperfine MRI, also known as Swoop, is unique because it uses a portable, low-field magnet that is lightweight and does not require the heavy infrastructure of traditional MRI machines. This makes it more accessible and allows for brain imaging at the point of care, especially for critically ill patients, without the need for a dedicated MRI suite.2351112
Research Team
Sherwin Chan, MD PhD
Principal Investigator
Children's Mercy Kansas City
Eligibility Criteria
This trial is for pediatric patients aged from birth to 22 years at CMH Adele Hall. It's not suitable for those who need extra sedation or have non-MRI safe implants that can't be removed.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Imaging Assessment
Participants undergo MRI assessments using the Hyperfine MRI device to compare with standard of care imaging
Follow-up
Participants are monitored for safety and effectiveness after imaging assessments
Treatment Details
Interventions
- Hyperfine MRI
Hyperfine MRI is already approved in United States, European Union, United Kingdom for the following indications:
- Brain imaging of patients of all ages
- Brain imaging
- Brain imaging
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's Mercy Hospital Kansas City
Lead Sponsor